Filter
News & Insights
- Private Capital
Decoding private capital: A conversation with Ashley Roche, MEMCO
Read More - Clinical & Medical AffairsClinical Insider
Ulysses secures funding for hiring and expansion odyssey
Read More - Clinical & Medical AffairsClinical Insider
A2 Healthcare sets up in Boston to help biopharma with Japanese trials
Read More - Clinical & Medical AffairsClinical Insider
Influenza highest pandemic risk according to EU clinical research network
Read More - Wealth & Investment Management
3 lessons in climate litigation around the world
Read More - Wealth & Investment Management
Adjusted For Risk Podcast: An investment management special
Read More - Clinical & Medical AffairsClinical Insider
CDER launches C3TI to drive innovation in clinical trials
Read More - Clinical & Medical AffairsClinical Insider
NCTN to use Natera biomarker to guide treatment in urothelial cancer trial
Read More - Clinical & Medical AffairsClinical Insider
Explainer animations increasingly common in UK clinical trials, says study
Read More - Clinical & Medical AffairsClinical Insider
Experts predict tech innovation will establish three-phase trial model for new drugs
Read More - Partnering, Business Development & Licensing
Moving from Eminence-Based to Evidence-Based Healthcare
Read More - Clinical & Medical AffairsClinical Insider
EMA shares details of stakeholder collaboration platform
Read More - Clinical & Medical AffairsClinical Insider
Resonance Health to buy TrialsWest to build presence in study space
Read More - Clinical & Medical AffairsClinical Insider
Study says regulations covering multi-drug “platform studies” should be more flexible
Read More - Partnering, Business Development & Licensing
From Aspiration to Action: Navigating Sustainability in Biopharma
Read More - Clinical & Medical AffairsClinical Insider
Veeda buys Heads just weeks after appointing new CEO
Read More - Clinical & Medical AffairsClinical Insider
FSD hires iNGENu for Phase I MS drug study
Read More - Clinical & Medical AffairsClinical Insider
Frontage and EPS team to take on Japan’s “drug lag”
Read More - Wealth & Investment Management
Rising Above: Newcomers chipping away at impostor syndrome
Read More - Clinical & Medical AffairsClinical Insider
Government commits $22m to fund UK advanced therapy trials infrastructure
Read More